Herpes Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
Conditions:   Sarcoma;   Carcinoma;   Breast Cancer;   Pancreatic Cancer;   Colorectal Cancer;   Gastric Cancer;   Liver Cancer;   Lung Cancer;   Gynecologic Cancer Intervention:   Drug: Recombinant oncolytic herpes simplex virus type 1 (R130) Sponsors:   Shanghai Yunying Medical Technology;   The Affiliated Hospital of Xuzhou Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 16, 2023 Category: Research Source Type: clinical trials